he hemodynamic function of Starr-Edwards Tprosthetic valves has been studied extensivebut the circulatory dynamics following valve replacement with other prostheses, such as the Kay-Shiley disc valve, have been less well chara c t e r i~e d .~-~ Between January, 1966, and October, 1970, Kay-Shiley prostheses were used at the National Heart and Lung Institute to replace mitral and/or tricuspid valves in 48 patients. In addition to preoperative cardiac catheterization, 18 of the patients were also studied by catheterization six to 2 . 3 months (average, nine) after operation. The hemodynamic function of the Kay-Shiley prostheses in these 18 patients is the subject of this report.
Right heart catheterization was performed either through 'From the Cardiology Branch and Surgery Branch, National
Heart and Lung Institute, Bethesda. The type of operative procedure performed and the mortality figures for the entire group of 48 patients are summarized in Table 1 . In the study group of 18 patients, 16 were in atrial fibrillation preoperatively, and two were in sinus rhythm. Postoperatively these two and three additional patients were in sinus rhythm; the other 13 patients remained in atrial fibrillation.
Of the 14 patients with Kay-Shiley mitral prostheses, four also had Kay-Shiley prostheses in the tricuspid position, and two had Stan-Edwards aortic prostheses. Pertinent postoperative hemodynamic findings are summarized in Table 2 . In these 14 patients, the average cardiac index rose slightly from 2.2 L/min/M2 preoperatively to 2.8 L/min/M2 postoperatively ( P = < .07). Left atrial mean pressure at rest averaged 26 mmHg preoperatively and fell to 18 mmHg after operation ( P < .01) . Average left ventricular end-diastolic pressure dynamic data obtained in these eight patients are also included in Table 2 . The average cardiac index rose from 1.7 L/min/M2 preoperatively to 2.5 L/min/M2 postoperatively ( P = < .02). Average right atrial mean pressure decreased insignificantly from 13 mmHg preoperatively to 10 rnrnHg postoperatively, and in no patient was the postoperative right atrial mean pressure less than eight mmHg. The average right ventricular pressure fell insignificantly from 68/12 mmHg before to 5118 mmHg after operation. None of the patients with tricuspid prostheses had postoperative right ventricular cineangiograms.
The in uivo effective orifice areas of the KayShiley prostheses in the mitral position ranged from 1.3 to 2.1 cm2-59 percent to 95 percent (average, 
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77 percent) of the in vitro orifice areas provided by the manufacturer (Table 3 ) . The in vim effective orifice areas of the tricuspid prostheses ranged from 1.3 to 2.9 cm2-41 percent of 90 percent (average, 71 percent) of the in vitro orifice areas (Table 3 ) . In general, in vivo effective orifice areas were larger with the larger size prostheses.
At the National Heart and Lung Institute, KayShiley prostheses have been used for mitral valve replacement only in patients in whom at operation the left ventricle was judged to be too small to accommodate a Starr-Edwards prosthesis. Thirteen of the 14 patients with the Kay-Shiley mitral prosthesis had pure or predominant mitral stenosis; the 14th (No. 10) had acute severe mitral regurgitation without left ventricular dilatation. Consequently, the Kay-Shiley valves employed have been small. The size used most frequently was no. 4; sizes ranged from nos. 1 to 7 in the entire group and from nos. 3 to 6 in the 18 patients studied postoperatively. Thus, the left atrial pressures were higher, the mitral valvular gradients were larger, and the effective mitral orifice areas smaller in these patients than in those patients whose mitral valves were replaced with sizes 2 M, 3 M, and 4 M Starr-Edwards prostheses, models 6120 or 6310. 5 The left atrial pressures, valve gradients, and orifice areas in the present patients were similar, however, to those observed in patients with 2 M and 3 M Starr-Edwards model 6300 pros these^;^ this is not surprising, since these Starr-Edwards valves have in vitro orifice areas nearly identical to those of nos. 4 and 5 Kay-Shiley valves (Table 3) .
In this clinic disc valves are always utilized for tricuspid valve replacement because the disc prostheses do not project into the ventricular cavity as far and are better accommodated in the right ventricle than are ball valves.11 Most often tricuspid valve replacement was required because of tricuspid regurgitation (six of the eight), and, accordingly, most of the Kay-Shiley prostheses use? in the tricupsid position were larger (two were size 5 and 6 were size seven) than those employed in the mitral area. Consequently, the tricuspid prostheses, in general, had smaller diastolic pressure gradients and larger effective orifice areas than the mitral prostheses. However, pressure normally is quite low in the right atrium, and even these larger valves were sufficiently obstructive to maintain right atrial mean pressure considerably above the upper limit of normal ( 5 mmHg in this laboratory) in every patient.
In both the mitral and tricuspid positions, KayShiley prostheses had calculated effective orifice areas that were smaller than the in vitro orifice areas. We also have observed this in patients with Starr-Edwards prostheses, and the most likely explanation is the use of a constant in the Gorlin formula that is inappropriate for these prostheses.
During the past four years at the National Heart and Lung Institute, hospital mortality in patients undergoing mitral valve replacement with StarrEdwards prostheses has been 14 percent, whereas hospital mortality among patients in whom KayShiley prostheses were utilized has been 29 percent (Table 1 ) . Although this difference could be attributed to intrinsic differences in the prostheses, other explanations seem more likely. First, in 31 of the 48 patients some operative procedure in addition to mitral valve replacement was necessary (Table 1) . Second, it has been the experience in this as well as other clinics that the incidence of early and late postoperative complications is increased when mitral valve replacement is necessary in patients in whom the left ventricular cavity is small or normal in size.12 As previously mentioned, 13 of the 14 patients in the present study had pure or predominant mitral stenosis, and none of the 14 had dilatation of the left ventricle. A small or normal sized left ventricle frequently will not permit insertion of a Starr-Edwards prosthesis and will permit only a Kay-Shiley prosthesis of smaller size. When a small prosthesis must be used, significant residual mitral stenosis may r e s~l t .~ Thus, for the reasons stated above a critical comparison of Kay-Shiley and Starr-Edwards valves cannot be made on the basis of the data in this study. It appears likely that the higher operative mortality in patients in whom Kay-Shiley valves were inserted is related to patient selection rather than to the type of prosthesis employed, and in patients with left ventricles too small to accommodate ball valve prostheses, disc prostheses are still used at the National Heart and Lung Institute.
